血管壁MRI斑块强化与磷酸二酯酶4D基因变异在有症状颅内动脉粥样硬化患者卒中复发中的关联
该研究前瞻性纳入324例有症状颅内动脉粥样硬化患者,用血管壁MRI评估斑块强化并检测PDE4D基因单核苷酸多态性,随访中97例(29.9%)复发缺血性卒中;斑块强化(HR 4.52)与PDE4D83变异(HR 7.43)为复发的独立相关因素。
要点
- 有症状颅内动脉粥样硬化患者中78.4%可见斑块强化,强化组卒中复发率显著高于无强化组。
- 斑块强化与卒中复发独立相关(HR 4.52,95%CI 2.35–8.73,p<0.001)。
- PDE4D83变异携带者复发风险更高(HR 7.43,95%CI 1.75–31.87,p=0.005)。
核心结论
- 血管壁MRI上的斑块强化和PDE4D83变异的存在与有症状颅内动脉粥样硬化患者的缺血性卒中复发相关。
研究设计与样本
- 前瞻性纳入324例有症状颅内动脉粥样硬化患者,行血管壁MRI评估管腔和管壁改变,并通过直接测序检测PDE4D基因单核苷酸多态性(SNP32、SNP83、SNP87)。
- 采用多因素Cox比例风险模型分析卒中复发的危险因素。
关键影像表现/征象
- 血管壁MRI用于评估颅内动脉粥样硬化斑块性质及管腔和管壁改变。
诊断标准与关键数值
- 斑块强化预测卒中复发:HR 4.52(95%CI 2.35–8.73,p<0.001)。
- PDE4D83变异预测卒中复发:HR 7.43(95%CI 1.75–31.87,p=0.005)。
- 复发卒中患者PDE4D83的CT/CC基因型频率显著高于无复发患者(p=0.019和p<0.001)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Vessel wall MRI (VW-MRI) can be used to evaluate the nature of intracranial atherosclerosis (ICAS) plaque in vivo. Phosphodiesterase 4D (PDE4D) participates in stroke development. This study aims to explore the value of VW-MRI findings and the PDE4D gene variant in predicting stroke recurrence in patients with ICAS.
METHODS: We prospectively recruited 324 symptomatic ICAS patients. VW-MRI was performed to determine luminal and wall changes. PDE4D gene single-nucleotide polymorphisms (SNPs)-namely, SNP32, SNP83, and SNP87-were determined by direct sequencing. The risk factors of stroke recurrence were analyzed using the multivariate Cox proportional hazards model.
RESULTS: Of the 324 subjects, 97 (29.9%) experienced recurrent ischemic stroke during the follow-up period. A total of 254 patients (78.4%) showed plaque enhancement; 87 of these patients experienced stroke recurrence. The CT/CC genotype frequencies of PDE4D83 were significantly higher in participants with recurrent stroke than in patients without stroke recurrence (p = 0.019 and p < 0.001, respectively). However, the PDE4D32 and PDE4D87 variants were not correlated with recurrent stroke. Multivariate analysis showed that plaque enhancement from VW-MRI (HR 4.52, 95% CI 2.35-8.73, p < 0.001) and the PDE4D83 variant (HR 7.43, 95% CI 1.75-31.87, p = 0.005) were independently correlated with stroke recurrence. Kaplan-Meier curves showed significant differences in stroke recurrence rates between the plaque-enhanced group and the non-enhanced group (p < 0.001) and between the PDE4D83 variant carriers and noncarriers (p = 0.002).
CONCLUSION: Plaque enhancement on VW-MRI and the presence of the PDE4D83 variant are associated with ischemic stroke recurrence in subjects with symptomatic ICAS.
引用
- Xu, Qin, Yu, et al. Association of plaque enhancement on vessel wall MRI and the phosphodiesterase 4D variant with stroke recurrence in patients with symptomatic intracranial atherosclerosis. Neuroradiology. 2022. PMID: 35420310. doi:10.1007/s00234-022-02948-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。